{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:15Z","timestamp":1788385995446,"version":"build-2803163510"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmunity involves a loss of immune tolerance to self-proteins due to a combination of genetic susceptibility and environmental provocation, which generates autoreactive T and B cells. Genetic susceptibility affects lymphocyte autoreactivity at the level of central tolerance (e.g., defective, or incomplete MHC-mediated negative selection of self-reactive T cells) and peripheral tolerance (e.g., failure of mechanisms to control circulating self-reactive T cells). T regulatory cell (Treg) mediated suppression is essential for controlling peripheral autoreactive T cells. Understanding the genetic control of Treg development and function and Treg interaction with T effector and other immune cells is thus a key goal of autoimmunity research. Herein, we will review immunogenetic control of tolerance in one of the classic models of autoimmunity, the non-obese diabetic (NOD) mouse model of autoimmune Type 1 diabetes (T1D). We review the long (and still evolving) elucidation of how one susceptibility gene,<jats:italic>Cd137<\/jats:italic>, (identified originally<jats:italic>via<\/jats:italic>linkage studies) affects both the immune response and its regulation in a highly complex fashion. The CD137 (present in both membrane and soluble forms) and the CD137 ligand (CD137L) both signal into a variety of immune cells (bi-directional signaling). The overall outcome of these multitudinous effects (either tolerance or autoimmunity) depends upon the balance between the regulatory signals (predominantly mediated by soluble CD137<jats:italic>via<\/jats:italic>the CD137L pathway) and the effector signals (mediated by both membrane-bound CD137 and CD137L). This immune balance\/homeostasis can be decisively affected by genetic (susceptibility vs. resistant alleles) and environmental factors (stimulation of soluble CD137 production). The discovery of the homeostatic immune effect of soluble CD137 on the CD137-CD137L system makes it a promising candidate for immunotherapy to restore tolerance in autoimmune diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2022.918837","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T06:50:39Z","timestamp":1658472639000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"Manuel","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke S.","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weici","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","article-title":"Autoimmunity: From bench to bedside","volume-title":"Autoimmunity: From Bench to Bedside","author":"Anaya","year":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/254319","article-title":"Introducing polyautoimmunity: Secondary autoimmune diseases no longer exist","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimm Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int J Celiac Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.11.012","article-title":"The autoimmune tautology. a summary of evidence","volume":"84","author":"Anaya","year":"2017","journal-title":"Joint Bone Spine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding hla-Drb1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","article-title":"Cytokine and autoantibody clusters interaction in systemic lupus erythematosus","volume":"15","author":"Pacheco","year":"2017","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14304","article-title":"Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: A systematic review and meta-analysis","volume":"93","author":"Botello","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.03.006","article-title":"Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes","volume":"60","author":"Tomer","year":"2015","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12967-015-0525-x","article-title":"Novel and rare functional genomic variants in multiple autoimmune syndrome and sj\u00f6gren's syndrome","volume":"13","author":"Johar","year":"2015","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214127","article-title":"Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases","volume":"78","author":"Acosta-Herrera","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing il-2 receptor alpha-chains (Cd25). breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of Cd4+Cd25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ni909","article-title":"An essential role for scurfin in Cd4+Cd25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (Ipex) and ipex-like syndrome","volume":"8","author":"Jamee","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From ipex syndrome to Foxp3 mutation: A lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Amaya-Uribe","year":"2019","journal-title":"J Autoimmun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.09.004","article-title":"B cell targeted therapies in autoimmune disease","volume":"61","author":"Barnas","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose il-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: A phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00651","article-title":"Antigen-specific regulatory T cells and low dose of il-2 in treatment of type 1 diabetes","volume":"6","author":"Pham","year":"2016","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.20","article-title":"Regulatory T cells: Immune suppression and beyond","volume":"7","author":"Wan","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878","article-title":"Tgf-Beta-Induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing rorgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2013early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promotion Perspect"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12856","article-title":"High prevalence of comorbid autoimmune diseases in adults with type 1 diabetes from the healthfacts database","volume":"11","author":"Bao","year":"2019","journal-title":"J Diabetes"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.7.3585","article-title":"Dendritic cells and macrophages are the first and major producers of tnf-alpha in pancreatic islets in the nonobese diabetic mouse","volume":"160","author":"Dahl\u00e9n","year":"1998","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/labinvest.3700238","article-title":"Dendritic cells and macrophages are essential for the retention of lymphocytes in (Peri)-insulitis of the nonobese diabetic mouse: A phagocyte depletion study","volume":"85","author":"Nikolic","year":"2005","journal-title":"Lab Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.08.005","article-title":"Immune mechanisms in type 1 diabetes","volume":"34","author":"W\u00e5llberg","year":"2013","journal-title":"Trends Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030966","article-title":"Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model","volume":"198","author":"Turley","year":"2003","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2015.04.009","article-title":"Type 1 diabetes and T regulatory cells","volume":"98","author":"ElEssawy","year":"2015","journal-title":"Pharmacol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0038","article-title":"Administration of Cd4+Cd25highcd127- regulatory T cells preserves B-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with Cd4(+)Cd25(High)Cd127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1538\/expanim1978.29.1_1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000828","article-title":"Development of the nonobese diabetic mouse and contribution of animal models for understanding type 1 diabetes","volume":"46","author":"Mullen","year":"2017","journal-title":"Pancreas"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1385\/IR:36:1:189","article-title":"Dissecting genetic control of autoimmunity in nod congenic mice","volume":"36","author":"Ridgway","year":"2006","journal-title":"Immunol Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2435","article-title":"The first external domain of the nonobese diabetic mouse class ii I-a beta chain is unique","volume":"84","author":"Acha-Orbea","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.3368786","article-title":"A molecular basis for mhc class ii\u2013associated autoimmunity","volume":"240","author":"Todd","year":"1988","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191383798","article-title":"Transgenic rescue implicates Beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (Nod) mice","volume":"98","author":"Hamilton-Williams","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nature06406","article-title":"Localization of type 1 diabetes susceptibility to the mhc class I genes hla-b and hla-a","volume":"450","author":"Nejentsev","year":"2007","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.20.9566","article-title":"An abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells","volume":"90","author":"Singer","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/345724a0","article-title":"Prevention of diabetes in non-obese diabetic I-ak transgenic mice","volume":"345","author":"Slattery","year":"1990","journal-title":"Nature"},{"key":"B49","article-title":"Novel autoantigens in type 1 diabetes","volume":"5","author":"Han","year":"2013","journal-title":"Am J Trans Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.6.1639","article-title":"Genetic control of diabetes and insulitis in the nonobese diabetic (Nod) mouse","volume":"165","author":"Wicker","year":"1987","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6580","article-title":"Increased nonobese diabetic Th1:Th2 (Ifn-Gamma:Il-4) ratio is Cd4+ T cell intrinsic and independent of apc genetic background","volume":"169","author":"Koarada","year":"2002","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1693","article-title":"Increased entry into the ifn-gamma effector pathway by Cd4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57bl\/6 genetic background","volume":"167","author":"Koarada","year":"2001","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12065","article-title":"Transient depletion of Cd4+ Cd25+ regulatory T cells results in multiple autoimmune diseases in wild-type and b-Cell-Deficient nod mice","volume":"139","author":"Ellis","year":"2013","journal-title":"Immunology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13027","article-title":"Loss of immune tolerance to il-2 in type 1 diabetes","volume":"7","author":"P\u00e9rol","year":"2016","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80195-8","article-title":"B7\/Cd28 costimulation is essential for the homeostasis of the Cd4+Cd25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factor-alpha regulation of Cd4+Cd25+ T cell levels in nod mice","volume":"99","author":"Wu","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810713105","article-title":"The defect in T-cell regulation in nod mice is an effect on the T-cell effectors","volume":"105","author":"D'Alise","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1042\/BST0360312","article-title":"Commonality in the genetic control of type 1 diabetes in humans and nod mice: Variants of genes in the il-2 pathway are associated with autoimmune diabetes in both species","volume":"36","author":"Rainbow","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"B59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2005.09.009","article-title":"Type 1 diabetes genes and pathways shared by humans and nod mice","author":"Wicker","year":"2005","journal-title":"J Autoimmun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)00806-7","article-title":"Gene-gene interactions in the nod mouse model of type 1 diabetes","volume":"100","author":"Ridgway","year":"2008","journal-title":"Adv Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/351542a0","article-title":"Genetic analysis of autoimmune type 1 diabetes mellitus in mice","volume":"351","author":"Todd","year":"1991","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ng0893-404","article-title":"Polygenic control of autoimmune diabetes in nonobese diabetic mice","volume":"4","author":"Ghosh","year":"1993","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.10.1186","article-title":"Crosses of nod mice with the related non strain. a polygenic model for iddm","volume":"44","author":"McAleer","year":"1995","journal-title":"Diabetes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nri1031","article-title":"Congenic mice: Cutting tools for complex immune disorders","volume":"3","author":"Rogner","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00281-010-0204-1","article-title":"Mouse models for the study of autoimmune type 1 diabetes: A nod to similarities and differences to human disease","volume":"33","author":"Driver","year":"2011","journal-title":"Semin Immunopathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1101\/gr.10.4.446","article-title":"Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: Identification of a candidate segment of ancestral DNA by haplotype mapping","volume":"10","author":"Lyons","year":"2000","journal-title":"Genome Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.10.1744","article-title":"Nod Idd5 locus controls insulitis and diabetes and overlaps the orthologous Ctla4\/Iddm12 and Nramp1 loci in humans","volume":"49","author":"Hill","year":"2000","journal-title":"Diabetes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.3.882","article-title":"Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in nod congenic mice","volume":"52","author":"Robles","year":"2003","journal-title":"Diabetes"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2012.9.169","article-title":"Comparative genetics: Synergizing human and nod mouse studies for identifying genetic causation of type 1 diabetes","volume":"9","author":"Driver","year":"2012","journal-title":"Rev Diabetes Stud"},{"key":"B70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2018.06.002","article-title":"The genetic architecture of type 1 diabetes mellitus","volume":"477","author":"Nyaga","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/ng1958","article-title":"Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity","volume":"39","author":"Yamanouchi","year":"2007","journal-title":"Nat Genet"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.02.005","article-title":"Il-2 therapy in type 1 diabetes: \"Trials\" and tribulations","volume":"149","author":"Long","year":"2013","journal-title":"Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.1038\/s41598-018-26161-6","article-title":"Treatment of T1d Via optimized expansion of antigen-specific tregs induced by il-2\/Anti-Il-2 monoclonal antibody complexes and Peptide\/Mhc tetramers","volume":"8","author":"Izquierdo","year":"2018","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s42003-021-02721-x","article-title":"Therapeutically expanded human regulatory T-cells are super-suppressive due to Hif1a induced expression of Cd73","volume":"4","author":"Jarvis","year":"2021","journal-title":"Commun Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.12688\/wellcomeopenres.15697.1","article-title":"Interleukin-2 therapy of autoimmunity in diabetes (Itad): A phase 2, multicentre, double-blind, randomized, placebo-controlled trial","volume":"5","author":"Marcovecchio","year":"2020","journal-title":"Wellcome Open Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene Ctla4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1727885","article-title":"Ctla4-ig (Abatacept): A promising investigational drug for use in type 1 diabetes","volume":"29","author":"Rachid","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-014-0438-4","article-title":"Insulitis in human type 1 diabetes: A comparison between patients and animal models","volume":"36","author":"In't Veld","year":"2014","journal-title":"Semin Immunopathol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-Cd3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)00012-1","article-title":"The nod Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137","volume":"13","author":"Lyons","year":"2000","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1038\/s41598-019-40898-8","article-title":"Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus","volume":"9","author":"Forsberg","year":"2019","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2005.04.007","article-title":"Genetic and functional association of the immune signaling molecule 4-1bb (Cd137\/Tnfrsf9) with type 1 diabetes","volume":"25","author":"Cannons","year":"2005","journal-title":"J Autoimmun"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MR1119-224R","article-title":"The relevance of soluble Cd137 in the regulation of immune responses and for immunotherapeutic intervention","volume":"107","author":"Luu","year":"2020","journal-title":"J Leuk Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S117264","article-title":"Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes","volume":"6","author":"Itoh","year":"2017","journal-title":"ImmunoTargets Ther"},{"key":"B87","article-title":"Inducible T cell antigen 4-1bb","volume":"150","author":"Pollok","year":"1993","journal-title":"Anal Expression Funct J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.6.1963","article-title":"Cdna sequences of two inducible T-cell genes","volume":"86","author":"Kwon","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ni743","article-title":"Homeostasis and anergy of Cd4(+)Cd25(+) suppressor T cells in vivo","volume":"3","author":"Gavin","year":"2002","journal-title":"Nat Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00280-7","article-title":"Cd4(+)Cd25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced tnf receptor","volume":"16","author":"McHugh","year":"2002","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1003491","article-title":"4-1bb-Dependent inhibition of immunosuppression by activated Cd4+Cd25+ T cells","volume":"75","author":"Choi","year":"2004","journal-title":"J Leuk Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2428","article-title":"The 4-1bb costimulation augments the proliferation of Cd4+Cd25+ regulatory T cells","volume":"173","author":"Zheng","year":"2004","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0793","article-title":"Modulating protective and pathogenic Cd4+ subsets via Cd137 in type 1 diabetes","volume":"56","author":"Irie","year":"2007","journal-title":"Diabetes"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101013","article-title":"The B10 Idd9.3 locus mediates accumulation of functionally superior Cd137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model","volume":"189","author":"Kachapati","year":"2012","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1998.1396","article-title":"Nk1.1 cells express 4-1bb (Cdw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1bb monoclonal antibodies","volume":"190","author":"Melero","year":"1998","journal-title":"Cell Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240215","article-title":"4-1bb T-cell antigen binds to mature b cells and macrophages, and costimulates anti-Mu-Primed splenic b cells","volume":"24","author":"Pollok","year":"1994","journal-title":"Eur J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.08.025","article-title":"Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"112","author":"Chitnis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1632","article-title":"Identification of regulatory functions for 4-1bb and 4-1bbl in myelopoiesis and the development of dendritic cells","volume":"9","author":"Lee","year":"2008","journal-title":"Nat Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830231037","article-title":"Molecular cloning of a ligand for the inducible T cell gene 4-1bb: A member of an emerging family of cytokines with homology to tumor necrosis factor","volume":"23","author":"Goodwin","year":"1993","journal-title":"Eur J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02618","article-title":"Cd137 (4-1bb) signalosome: Complexity is a matter of trafs","volume":"9","author":"Zapata","year":"2018","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e000733","DOI":"10.1136\/esmoopen-2020-000733","article-title":"New emerging targets in cancer immunotherapy: Cd137\/4-1bb costimulatory axis","volume":"4","author":"Etxeberria","year":"2020","journal-title":"ESMO Open"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1313","article-title":"4-1bb ligand induces cell division, sustains survival, and enhances effector function of Cd4 and Cd8 T cells with similar efficacy","volume":"167","author":"Cannons","year":"2001","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.1.558","article-title":"4-1bb and Ox40 are members of a tumor necrosis factor (Tnf)-nerve growth factor receptor subfamily that bind tnf receptor-associated factors and activate nuclear factor kappab","volume":"18","author":"Arch","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.8016","article-title":"Human 4-1bb (Cd137) signals are mediated by Traf2 and activate nuclear factor-kappa b","volume":"242","author":"Jang","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B105","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.6.2990","article-title":"Role of the stress kinase pathway in signaling Via the T cell costimulatory receptor 4-1bb","volume":"163","author":"Cannons","year":"1999","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6193","article-title":"Role of tnf receptor-associated factor 2 and P38 mitogen-activated protein kinase activation during 4-1bb-Dependent immune response","volume":"165","author":"Cannons","year":"2000","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8252","article-title":"4-1bbl induces tnf receptor-associated factor 1-dependent bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired hiv-specific Cd8 T cells","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8093","article-title":"Erk-dependent bim modulation downstream of the 4-1bb-Traf1 signaling axis is a critical mediator of Cd8 T cell survival in vivo","volume":"180","author":"Sabbagh","year":"2008","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1112579","article-title":"Leukocyte-specific protein 1 links tnf receptor-associated factor 1 to survival signaling downstream of 4-1bb in T cells","volume":"93","author":"Sabbagh","year":"2013","journal-title":"J Leuk Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4110\/in.2009.9.3.84","article-title":"Cd137-Cd137 ligand interactions in inflammation","volume":"9","author":"Kwon","year":"2009","journal-title":"Immune Netw"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4110\/in.2012.12.5.176","article-title":"Regulation of inflammation by bidirectional signaling through Cd137 and its ligand","volume":"12","author":"Kwon","year":"2012","journal-title":"Immune Netw"},{"key":"B112","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.6.2600","article-title":"Signals through 4-1bb are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death","volume":"158","author":"Hurtado","year":"1997","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.2.551","article-title":"Costimulation of Cd28- T lymphocytes by 4-1bb ligand","volume":"158","author":"DeBenedette","year":"1997","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.9.4882","article-title":"4-1bb promotes the survival of Cd8+ T lymphocytes by increasing expression of bcl-xl and bfl-1","volume":"169","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"B115","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.9.5037","article-title":"Cutting edge: 4-1bb is a bona fide Cd8 T cell survival signal","volume":"162","author":"Takahashi","year":"1999","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171068","article-title":"4-1bb costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J Exp Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/2326-6066.CIR-17-0767","article-title":"Mitochondrial morphological and functional reprogramming following Cd137 (4-1bb) costimulation","volume":"6","author":"Teijeira","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1bb costimulatory signals preferentially induce Cd8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses","volume":"186","author":"Shuford","year":"1997","journal-title":"J Exp Med"},{"key":"B119","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.9.4833","article-title":"Analysis of 4-1bb ligand (4-1bbl)-Deficient mice and of mice lacking both 4-1bbl and Cd28 reveals a role for 4-1bbl in skin allograft rejection and in the cytotoxic T cell response to influenza virus","volume":"163","author":"DeBenedette","year":"1999","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.9.4859","article-title":"4-1bb ligand, a member of the tnf family, is important for the generation of antiviral Cd8 T cell responses","volume":"163","author":"Tan","year":"1999","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5483","article-title":"Immune responses in 4-1bb (Cd137)-deficient mice","volume":"168","author":"Kwon","year":"2002","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2567.2004.01952.x","article-title":"Engagement of the Cd137 (4-1bb) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance","volume":"113","author":"Foell","year":"2004","journal-title":"Immunology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1bb T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M","article-title":"Expression and costimulatory effects of the tnf receptor superfamily members Cd134 (Ox40) and Cd137 (4-1bb), and their role in the generation of anti-tumor immune responses","volume":"32","author":"Taraban","year":"2002","journal-title":"Eur J Immunol"},{"key":"B125","article-title":"Anti-4-1bb monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific Cd8+ T cells","volume":"62","author":"May","year":"2002","journal-title":"Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22126210","article-title":"4-1bbl as a mediator of cross-talk between innate, adaptive, and regulatory immunity against cancer","volume":"22","author":"Martinez-Perez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/14.3.275","article-title":"Expression and function of 4-1bb and 4-1bb ligand on murine dendritic cells","volume":"14","author":"Futagawa","year":"2002","journal-title":"Int Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cellimm.2003.11.003","article-title":"4-1bb-ligand is regulated on human dendritic cells and induces the production of il-12","volume":"226","author":"Laderach","year":"2003","journal-title":"Cell Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902713","article-title":"Dendritic cells and Stat3 are essential for Cd137-induced Cd8 T cell activation-induced cell death","volume":"184","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nature05478","article-title":"Foxp3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"Marson","year":"2007","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051409","article-title":"Where Cd4+Cd25+ T reg cells impinge on autoimmune diabetes","volume":"202","author":"Chen","year":"2005","journal-title":"J Exp Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671579","article-title":"Tr1 cells as a key regulator for maintaining immune homeostasis in transplantation","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3179","article-title":"Coexpression of Cd49b and lag-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/nm1202-796","article-title":"Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease","volume":"8","author":"Sun","year":"2002","journal-title":"Nat Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2003.tb06052.x","article-title":"Cd137-mediated T cell Co-stimulation terminates existing autoimmune disease in sle-prone Nzb\/Nzw F1 mice","volume":"987","author":"Foell","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.3.1457","article-title":"Administration of agonistic anti-4-1bb monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis","volume":"168","author":"Sun","year":"2002","journal-title":"J Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nm1107","article-title":"4-1bb-Mediated immunotherapy of rheumatoid arthritis","volume":"10","author":"Seo","year":"2004","journal-title":"Nat Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165605","article-title":"Agonist-induced 4-1bb activation prevents the development of sj\u00f6gren's syndrome-like sialadenitis in non-obese diabetic mice","volume":"1866","author":"Zhou","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.06.001","article-title":"Administration of agonistic anti-4-1bb monoclonal antibody leads to the amelioration of inflammatory bowel disease","volume":"101","author":"Lee","year":"2005","journal-title":"Immunol Lett"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.10.1535","article-title":"Anti-4-1bb monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy","volume":"190","author":"Mittler","year":"1999","journal-title":"J Exp Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2003.11.002","article-title":"Cd137 signaling interferes with activation and function of Cd4+Cd25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis","volume":"226","author":"Morris","year":"2003","journal-title":"Cell Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(95)00349-b","article-title":"A mrna variant encoding a soluble form of 4-1bb, a member of the murine Ngf\/Tnf receptor family","volume":"164","author":"Setareh","year":"1995","journal-title":"Gene"},{"key":"B143","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaut.2013.09.002","article-title":"Recombinant soluble Cd137 prevents type one diabetes in nonobese diabetic mice","volume":"47","author":"Kachapati","year":"2013","journal-title":"J Autoimmun"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4262","article-title":"Cutting edge: Expression of functional Cd137 receptor by dendritic cells","volume":"168","author":"Wilcox","year":"2002","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S","article-title":"A soluble form of Cd137 (Ila\/4-1bb), a member of the tnf receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis","volume":"28","author":"Michel","year":"1998","journal-title":"Eur J Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.05.028","article-title":"Characterisation of soluble murine Cd137 and its association with systemic lupus","volume":"45","author":"Shao","year":"2008","journal-title":"Mol Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17010003","article-title":"The role of alternative splicing in the control of immune homeostasis and cellular differentiation","volume":"17","author":"Yabas","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02566","article-title":"Soluble Cd137 ameliorates acute type 1 diabetes by inducing T cell anergy","volume":"10","author":"Itoh","year":"2019","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0130","article-title":"The soluble ctla-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function","volume":"60","author":"Gerold","year":"2011","journal-title":"Diabetes"},{"key":"B150","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13317-010-0011-7","article-title":"The soluble ctla-4 receptor and its role in autoimmune diseases: An update","volume":"1","author":"Saverino","year":"2010","journal-title":"Auto Immun Highlights"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/215763","article-title":"The soluble form of ctla-4 from serum of patients with autoimmune diseases regulates T-cell responses","volume":"2014","author":"Simone","year":"2014","journal-title":"BioMed Res Int"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0623","article-title":"Expression of soluble Cd137 correlates with activation-induced cell death of lymphocytes","volume":"12","author":"Michel","year":"2000","journal-title":"Cytokine"},{"key":"B153","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.155.7.3360","article-title":"Potential role of 4-1bb in T cell activation. comparison with the costimulatory molecule Cd28","volume":"155","author":"Hurtado","year":"1995","journal-title":"J Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2337\/db13-0192","article-title":"Gene targeting in nod mouse embryos using zinc-finger nucleases","volume":"63","author":"Chen","year":"2014","journal-title":"Diabetes"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601851","article-title":"Cd137 plays both pathogenic and protective roles in type 1 diabetes development in nod mice","volume":"198","author":"Forsberg","year":"2017","journal-title":"J Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900485","article-title":"The Cd137 ligand is important for type 1 diabetes development but dispensable for the homeostasis of disease-suppressive Cd137(+) Foxp3(+) regulatory Cd4 T cells","volume":"204","author":"Foda","year":"2020","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/emm.2004.2","article-title":"Serum concentrations of soluble 4-1bb and 4-1bb ligand correlated with the disease severity in rheumatoid arthritis","volume":"36","author":"Jung","year":"2004","journal-title":"Exp Mol Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/art.23667","article-title":"Potential novel biomarkers of disease activity in rheumatoid arthritis patients: Cxcl13, Ccl23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor","volume":"58","author":"Rioja","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2006.01796.x","article-title":"Increased soluble 4-1bb ligand (4-1bbl) levels in peripheral blood of patients with multiple sclerosis","volume":"64","author":"Liu","year":"2006","journal-title":"Scand J Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9092805","article-title":"Prevention of type 1 diabetes: Past experiences and future opportunities","volume":"9","author":"Beik","year":"2020","journal-title":"J Clin Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918837\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T09:54:59Z","timestamp":1676195699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918837\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2022.918837"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.918837","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"918837"}}